Skip to search formSkip to main contentSkip to account menu

Hetastarch

Known as: HYDROXYETHYL STARCH, Hetastarch [Chemical/Ingredient], HES 
A synthetic, nonionic hydroxyethyl derivative of starch used as a plasma expander when prepared in an isotonic solution. Upon intravenous… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
Brandstrup et al are to be congratulated for this randomized prospective study demonstrating a significant downside to high… 
2003
2003
Background: Hydroxyethyl starches (HES) have been shown to decrease clot strength and to increase coagulation times assessed by… 
2002
2002
We have previously observed that bolus fluid resuscitation in uncontrolled hemorrhagic shock induced by solid organ injury leads… 
2001
2001
Records are given for 43 species of insects and other small organisms not previously reported to be established in Hawaii. These… 
1999
1999
BACKGROUND The generation of iron-dependent toxic oxygen radicals during the initial resuscitation from hemorrhagic shock was… 
1996
1996
The purpose of this study was to determine the duration of action of a single dose of hetastarch, a synthetic colloid, in… 
1994
1994
The density-dependent purification of islets from several species of mammalian pancreata is improved by prior storage of the… 
1985
1985
32 volunteers, none of whom showed any symptoms for kidney, liver or pancreas disease, were given by infusion 500 ml of various… 
Review
1981
Review
1981
Fluosol-DA, 20%, a perfluorochemical whole blood substitute, was infused during Phase II and Phase III clinical trials at 24… 
Highly Cited
1980
Highly Cited
1980
The biodistributions of In-111 oxine (with and without leukocyte labeling) of Ga-67 citrate and of In-111 chloride were compared…